Menu Item

Case study

Genentech

Project Overview

BLS & Co. serves as location and incentivesadvisor to Roche, Swiss multinational healthcare company, and its subsidiaryGenentech, the South San Francisco-based biotechnology industry leader. Ourengagements with Roche date back to 2012 with three major projects announced asof 2026:

  • North Carolina- During our most recent engagements supporting Genentech, BLS & Co. managed a nationwide search for a new drug product manufacturing facility. BLS managed a nationwide site evaluation and incentives strategy leading to a site in Holly Springs, North Carolina to be selected – the company’s first in the Eastern U.S. The facility will invest a total of $2 billion and create 520 jobs.
  • Oregon - In 2018, BLS & Co. also supported Genentech’s selection of an office in the Lloyd District of Portland, Oregon, as a second location for its Access Solutions Patient Service Center, employing approximately 300 full-time specialists during the peak insurance benefit open season.
  • New York - In2012, Roche required assistance to fast-track a decision on the location of its new R&D center. Roche engaged BLS to manage site selection and incentives negotiations of the TCRC eventually led to the company selecting the East River Science Park on Manhattan’s east side. The new facility would invest $13M and relocate 200 positions from NJ. 

Results

  • Over $2 billion in planned investment
  • 1,000+ full-time jobs

Energy Services